Uncategorized

Evotec SE announced progress within the Company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline.

OKYO Pharma Limited announced that its planned trial evaluating the efficacy and safety of OK-101 in subjects with DED has been posted on the ClinicalTrials.gov public website.

Anaveon announced the first patient dosed with ANV419 in the OMNIA-2 study – a Phase I/II study assessing the safety, tolerability and preliminary efficacy of ANV419 for the treatment of patients with relapsed / refractory multiple myeloma as monotherapy and in combination with daratumumab and hyaluronidase-fihj1, or with lenalidomide plus dexamethasone.

Addex Therapeutics Ltd announced that it will participate in the following conferences during the first half of 2023.

Akeso Inc. released its 2022 annual report. During the reporting period, the company enjoyed booming business development and made breakthrough progress in drug innovation and development, commercialization and internationalization.

Innate Pharma SA, announced that the Company will hold a conference call on Thursday, March 23, 2023 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2022.

Sean Martin is stepping up as chief medical officer of the New York-based insurer, after Oscar’s old CMO left to become CMO of L.A. Care Health Plan in December.

Nonprofits are coming under increased criticism around whether the benefits they provide justify large tax breaks. Nonprofits were exempt from $28 billion in taxes in 2020, but spent $16 billion on charity care, according to new research.

The agency cited its need to take on bigger and more complex cases in areas like health privacy in its request on Tuesday for a $160 million funding boost.

The Sweden-based company, which already partnered with Ultra Clean as a distributor, said the deal will “significantly expand” its offerings to sterile reprocessing departments.